📰 Topline News
Page 10 - Topline News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Topline. Real-time updates on events, politics, business and more.
March 29, 2023
Intra-Cellular Therapies, Inc. announced positive topline results from Study 403 evaluating lumateperone 42mg as monotherapy in the treatment of major depressive episodes in patients with major... | March 29, 2023
March 29, 2023
Biomea Fusion, Inc. announced initial positive topline data for the first two cohorts of patients with type 2 diabetes mellitus enrolled in the Phase II portion of its ongoing Phase I/II clinical... | March 29, 2023
March 29, 2023
Topline Data Expected in 2Q 2023SEATTLE, Wash. and VANCOUVER, British Columbia, March 29, 2023 -- Achieve Life Sciences, Inc. , a late-stage pharmaceutical company committed to the global... | March 29, 2023
March 29, 2023
Positive topline data from BDC-1001 dose-escalation clinical study validates the ability of the Boltbody™ ISAC platform to generate anti-tumor activity with acceptable safetyBDC-1001 advances... | March 29, 2023
March 28, 2023
Enrollment continues in RECONNECT, a confirmatory pivotal Phase 3 trial of Zygel™ in patients with Fragile X syndrome; topline results expected first-half 2024 European Commission granted... | March 28, 2023
March 28, 2023
Completed Phase 1b/2a trial of VTP-300 met its primary and secondary endpointsVTP-300 is the first antigen-specific immunotherapy shown to induce sustained reductions in Hepatitis B surface antigen (HBsAg)Results
March 27, 2023
INTERCEPT-AD, a Phase 1 clinical trial of ACU193 in patients with early Alzheimer’s disease, completed enrollment in February 2023 Topline data expected in the third quarter of 2023 Cash, cash... | March 27, 2023
March 24, 2023
TREK-AD Phase 2b study of eblasakimab fully enrolled, topline data readout expected early July 2023Phase 2 proof-of-concept trial of farudodstat in alopecia areata expected to commence in the... | March 24, 2023
March 23, 2023
Phase 2 topline data readout for prevention of post-surgical abdominal adhesions on track for Q2 2023 Strong balance sheet with sufficient cash expected to fund operations into mid-2024 ... | March 23, 2023
March 23, 2023
Topline sales gained momentum post-Black Friday, improving sequentially through the fourth quarter including positive total comparable sales in January 2023Fiscal 2023 year-end inventories down 11%... | March 23, 2023